Generate Biomedicines Inc (GENB)

Finanzdaten der Generate Biomedicines Inc-Aktie (GENB)

*Alle Zahlen in Millionen

Enddatum des Zeitraums	2026-06-30	2026-03-31
Periodenlänge	3 Monate	3 Monate
Revenues	12.60%6.31	7.22
	9.24%77.93	71.34
Research and Development	11.27%64.33	57.81
Depreciation and Amortization	2.23%3.20	3.27
Operating Income/Loss	11.70%-71.61	-64.11
Nonoperating Income/Loss	81.86%4.41	2.43
Income/Loss From Continuing Operations Before Tax	8.94%-67.20	-61.69
Income Tax Expense/Benefit	89.29%0.05	0.03
	8.98%-67.26	-61.71
Attributable To Parent	9.45%-67.26	-61.45
Available To Common Stockholders, Basic	2.80%-67.26	-69.20
Attributable To Noncontrolling Interest	100.00%-	-0.27
Basic Average Shares	97.68%128.24	64.87
Diluted Average Shares	97.68%128.24	64.87
Basic Earnings Per Share	51.40%-0.52	-1.07
Diluted Earnings Per Share	51.40%-0.52	-1.07